// App-Quantinova.ai

Mo1902 AASLD : Hepatitis B Surface Antigen (HBsAg) Seroclearance Rate in a Multicenter U.S. Cohort Study

Researchers

Presenter

  • Pelu Tran

Principal Investigators

  • Kevin T. Chaung

  • Mindie H. Nguyen

  • Vincent G. Nguyen

  • Lily H. Kim

  • Huy N. Trinh

  • Jiayi Li

  • Jian Q. Zhang

  • Huy A. Nguyen

  • Walid Ayoub

  • Aijaz Ahmed

Medical Centers

  • Pacific Health Foundation, San Jose, CA

  • Division of Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, United States

  • Hematology/Oncology, Palo Alto Medical Foundation, Mountain View, CA

  • School of Medicine, Stanford University, Stanford, CA

  • San Jose Gastroenterology, San Jose, CA

  • Chinese Hospital, San Francisco, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Hepatitis B

  • Cirrhosis

  • Solid malignancies

Biomarkers

  • Alanine transaminase

  • Alpha-fetoprotein

  • Body mass index

  • Hepatitis B surface antigen

  • Hepatitis B e antigen

  • Serum hepatitis B virus DNA

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved